Vernaleken, I; Kumakura, Y; Cumming, P et al.
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challengeNeuroimage. Bd. 30. H. 4. 2006 S. 1332-1339
Siessmeier, T; Kienast, T; Wrase, J et al.
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.Eur J Neurosci. Bd. 24. H. 1. 2006 S. 305-13
Schreckenberger, MF; Egle, UT; Drecker, S et al.
Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidismJ Clin Endocrinol Metab. Bd. 91. 2006 S. 4786-91
Teipel, SJ; Willoch, F; Ishii, K et al.
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.Neurobiol Aging. Bd. 27. H. 5. 2006 S. 681-90
Fottner, C; Helisch, A; Schreckenberger, M et al.
Superiority of 6-[18F]-Fluorodopamin Positron Emission Tomography (DOPA-PET) versus [123J]-Metaiodobenzylguanidine (MIBG) Scintigraphy in the localization of extraadrenal or multifocal pheochromocytomas and paragangliomoas. 50th Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 114. 2006 S. P01-002
Schirrmacher, E; Beck, C; Brueckner, B et al.
Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases.Bioconjug Chem. Bd. 17. H. 2. 2006 S. 261-6
Gründer, G; Landvogt, C; Vernaleken, I et al.
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.Neuropsychopharmacology. Bd. 31. H. 5. 2006 S. 1027-35